Breaking News Instant updates and real-time market news.

2020-10-12 08:35:25 FCX Freeport McMoRan $17.23 / +0.425 (+2.53%) 08:35 10/12/20 10/12 08:35 10/12/20 08:35	Freeport McMoRan downgraded to Neutral from Buy at Citi Citi analyst Alexander Hacking downgraded Freeport McMoRan to Neutral from Buy.	22 Oct
FCX Freeport McMoRan $17.23 / +0.425 (+2.53%) 10/01/20 Deutsche Bank Deutsche Bank initiates 'Buy Catalyst Call' on Freeport McMoRan 09/24/20 Raymond James Freeport McMoRan price target raised to $17 from $13.50 at Raymond James 09/23/20 Freeport McMoRan upgraded to Overweight from Equal Weight at Morgan Stanley 09/23/20 Morgan Stanley Freeport McMoRan upgraded to Overweight from Equal Weight at Morgan Stanley

2020-10-12 08:35:25

FCX

Freeport McMoRan

$17.23 / +0.425 (+2.53%)

08:35

10/12/20

10/12

08:35

10/12/20

08:35

Freeport McMoRan downgraded to Neutral from Buy at Citi

Citi analyst Alexander Hacking downgraded Freeport McMoRan to Neutral from Buy.

22
Oct

FCX Freeport McMoRan

$17.23 / +0.425 (+2.53%)

10/01/20 Deutsche Bank: Deutsche Bank initiates 'Buy Catalyst Call' on Freeport McMoRan

09/24/20 Raymond James: Freeport McMoRan price target raised to $17 from $13.50 at Raymond James

09/23/20: Freeport McMoRan upgraded to Overweight from Equal Weight at Morgan Stanley

09/23/20 Morgan Stanley: Freeport McMoRan upgraded to Overweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Initiation	Fastly assumed with a Sell at Citi » 06:24 03/03/21 03/03 06:24 03/03/21 06:24 FSLY Fastly $70.91 / -6.42 (-8.30%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options FSLY Fastly $70.91 / -6.42 (-8.30%) 02/18/21 Fastly falls -10.0% 02/17/21 Fastly names Brett Shirk chief revenue officer 11/13/20 Fastly rises after Commerce says won't enforce TikTok shutdown order 10/30/20 Fastly issues update to Q3 shareholder letter FSLY Fastly $70.91 / -6.42 (-8.30%) 02/18/21 Raymond James Fastly price target raised to $95 from $85 at Raymond James 01/22/21 Piper Sandler Fastly 2021 sales guidance to miss expectations, says Piper Sandler 01/21/21 Fly Intel: Top five analyst upgrades 01/21/21 Oppenheimer Fastly upgraded to Outperform at Oppenheimer FSLY Fastly $70.91 / -6.42 (-8.30%) 02/17/21 Fastly sees FY21 adjusted EPS (44c)-(35c), consensus (21c) 02/17/21 Fastly sees Q1 adjusted EPS (13c)-(9c), consensus (9c) 02/17/21 Fastly reports Q4 adjusted EPS (9c), consensus (10c) 02/17/21 Notable companies reporting after market close 21 May FSLY Fastly $70.91 / -6.42 (-8.30%) 12/08/20 Cloudflare, Fastly working with Apple to create Oblivious DNS, AppleInsider says FSLY Fastly $70.91 / -6.42 (-8.30%) 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: After-Hours Movers 12/08/20 Fastly jumps after report of DNS work with Apple FSLY Fastly $70.91 / -6.42 (-8.30%) 02/22/21 Unusually active option classes on open February 22nd 02/17/21 Fastly Inc options imply 20.2% move in share price post-earnings 02/12/21 Unusually active option classes on open February 12th 01/21/21 Unusually active option classes on open January 21st
Upgrade	Europcar Mobility upgraded to Hold from Reduce at HSBC » 06:24 03/03/21 03/03 06:24 03/03/21 06:24 EURMF Europcar Mobility $0.00 / + (+0.00%) HSBC analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EURMF Europcar Mobility $0.00 / + (+0.00%) 05:29 Today HSBC Europcar Mobility upgraded to Hold from Reduce at HSBC
Syndicate	Oscar Health 31M share IPO priced at $39.00 » 06:24 03/03/21 03/03 06:24 03/03/21 06:24 OSCR Oscar Health $0.00 / + (+0.00%) The deal priced above the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 03 Mar OSCR Oscar Health $0.00 / + (+0.00%) 02/28/21 Opening Day: Coinbase files to go public
Initiation	Dynatrace assumed with a Buy at Citi » 06:23 03/03/21 03/03 06:23 03/03/21 06:23 DT Dynatrace $52.20 / -1.14 (-2.14%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DT Dynatrace $52.20 / -1.14 (-2.14%) 02/03/21 Dynatrace rises 14.9% 01/28/21 Dynatrace expands strategic partnership with Google Cloud 01/20/21 Dynatrace CEO sells 55K shares of common stock 12/17/20 Dynatrace CEO sells 55K shares of common stock DT Dynatrace $52.20 / -1.14 (-2.14%) 02/04/21 Dynatrace price target raised to $50 from $40 at Loop Capital 02/04/21 Dynatrace price target raised to $65 from $50 at DA Davidson 02/04/21 JPMorgan Dynatrace price target raised to $67 from $50 at JPMorgan 02/04/21 Dynatrace price target raised to $60 from $50 at Truist DT Dynatrace $52.20 / -1.14 (-2.14%) 02/03/21 Dynatrace raises FY21 adj. EPS view to 61c-62c from 55c-57c, consensus 56c 02/03/21 Dynatrace sees Q4 non-GAAP EPS 13c-14c, consensus 12c 02/03/21 Dynatrace reports Q3 adjusted EPS 17c, consensus 13c 10/28/20 Dynatrace raises FY21 adj. EPS view to 55c-57c from 46c-49c, consensus 48c 09 Dec 03 Aug 03 Jun DT Dynatrace $52.20 / -1.14 (-2.14%) 10/28/20 Fly Intel: Pre-market Movers
Initiation	DocuSign assumed with a Buy at Citi » 06:22 03/03/21 03/03 06:22 03/03/21 06:22 DOCU DocuSign $232.46 / -6.16 (-2.58%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DOCU DocuSign $232.46 / -6.16 (-2.58%) 02/11/21 DocuSign COO sells 5.8K shares of common stock 02/04/21 DocuSign joins Duck Creek Partner Ecosystem 01/04/21 DocuSign CEO says investing 'aggressively,' sees 'tremendous' amount of runway 12/03/20 DocuSign jumps 7% to $247.88 after Q3 results beat estimates DOCU DocuSign $232.46 / -6.16 (-2.58%) 02/17/21 Wedbush DocuSign price target raised to $300 from $270 at Wedbush 02/03/21 Piper Sandler Piper raises 'bull-case' for DocuSign to $375, calls top idea for 2021 01/05/21 Piper Sandler DocuSign upgraded on 'sticky' e-signature demand at Piper Sandler 01/04/21 Piper Sandler DocuSign upgraded to Overweight from Neutral at Piper Sandler DOCU DocuSign $232.46 / -6.16 (-2.58%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 12/03/20 DocuSign sees FY21 revenue $1.426B-$1.430B, consensus $1.39B 12/03/20 DocuSign sees Q4 revenue $404M-$408M, consensus $387.34M 12/03/20 DocuSign reports Q3 non-GAAP EPS 22c, consensus 13c DOCU DocuSign $232.46 / -6.16 (-2.58%) 12/21/20 Mary Meeker's Bond invests in Ironclad at $1B valuation, The Information says DOCU DocuSign $232.46 / -6.16 (-2.58%) 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 12/04/20 Fly Intel: Pre-market Movers 12/03/20 Fly Intel: After-Hours Movers 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 03/11/21 DocuSign - DOCU 03/24/21 DocuSign, Inc. DOCU DocuSign $232.46 / -6.16 (-2.58%) 01/12/21 Unusually active option classes on open January 12th 12/03/20 DocuSign options imply 11.4% move in share price post-earnings 11/11/20 DocuSign call buyer realizes 120% same-day gains 10/14/20 Unusually active option classes on open October 14th

Syndicate	Aslan Pharmaceuticals 15M share Secondary priced at $4.00 » 06:22 03/03/21 03/03 06:22 03/03/21 06:22 ASLN Aslan Pharmaceuticals $4.34 / -0.88 (-16.86%) Jefferies and Piper… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ASLN Aslan Pharmaceuticals $4.34 / -0.88 (-16.86%) 03/01/21 Aslan Pharmaceuticals reports 'positive' results from study of ASLAN004 02/18/21 Aslan Pharmaceuticals appoints Neil Graham to board of directors 01/26/21 Aslan Pharma's ASLAN003 shows potential for best-in-class DHODH inhibitor 10/22/20 Aslan Pharmaceuticals initiates third dose cohort of ASLAN004 ASLN Aslan Pharmaceuticals $4.34 / -0.88 (-16.86%) 03/01/21 Piper Sandler Piper boosts Aslan target to $10 after positive atopic dematitis data 04/13/20 Piper Sandler Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler 03/18/20 Piper Sandler Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler ASLN Aslan Pharmaceuticals $4.34 / -0.88 (-16.86%) 11/09/20 Aslan Pharmaceuticals reports Q3 EPS (2c), two est. (9c) 03 Mar ASLN Aslan Pharmaceuticals $4.34 / -0.88 (-16.86%) 03/01/21 Fly Intel: After-Hours Movers
Initiation	Citrix assumed with a Buy at Citi » 06:21 03/03/21 03/03 06:21 03/03/21 06:21 CTXS Citrix / + Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CTXS Citrix / + 01/19/21 Citrix raises quarterly dividend to 37c from 35c per share 01/19/21 Citrix to acquire Wrike for $2.25B in cash 01/19/21 Citrix to acquire Wrike for $2.25B in cash 10/20/20 Citrix and Upwork expand collaboration in flexible work models, talent access CTXS Citrix / + 01/20/21 RBC Capital Citrix price target raised to $150 from $145 at RBC Capital 01/20/21 Citi Citrix shares remain 'attractively priced,' says Citi 10/23/20 Morgan Stanley Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley 10/23/20 RBC Capital Citrix price target lowered to $145 from $162 at RBC Capital CTXS Citrix / + 01/19/21 Citrix sees FY21 adjusted EPS $6.20-$6.40, consensus $6.37 01/19/21 Citrix sees Q1 adjusted EPS $1.40-$1.45, consensus $1.47 01/19/21 Citrix reports Q4 adjusted EPS $1.46, consensus $1.33 10/22/20 Citrix sees FY21 EPS 6.20-$6.40, consensus $6.19 CTXS Citrix / + 10/14/20 Microsoft resumption, Nio upgrade among top calls on Wall Street
Recommendations	International Game price target raised to $25 from $22 at Macquarie » 06:21 03/03/21 03/03 06:21 03/03/21 06:21 IGT International Game $18.37 / -0.37 (-1.97%) Macquarie analyst Chad… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options IGT International Game $18.37 / -0.37 (-1.97%) 03/01/21 International Game, Scientific Games sign cross-licensing agreement 02/16/21 International Game extends agreement with Mexico national lottery through 2022 02/01/21 International Game subsidiary signs four-year extension with Kentucky Lottery 01/26/21 International Game platform powers FanDuel Sportsbook mobile app IGT International Game $18.37 / -0.37 (-1.97%) 01/19/21 Jefferies International Game upgraded to Buy from Hold at Jefferies 01/14/21 Truist International Game upgraded to Buy from Hold at Truist 01/12/21 Argus International Game upgraded to Buy from Hold at Argus 01/07/21 Deutsche Bank International Game price target raised to $25 from $16 at Deutsche Bank IGT International Game $18.37 / -0.37 (-1.97%) 03/02/21 International Game reports Q4 EPS ($1.18) vs. (82c) last year 11/11/20 International Game reports Q3 adjusted EPS 26, consensus (21c) IGT International Game $18.37 / -0.37 (-1.97%) 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 11/11/20 Fly Intel: After-Hours Movers 10/14/20 Fly Intel: After-Hours Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference IGT International Game $18.37 / -0.37 (-1.97%) 10/13/20 $560K strangle seller in International Game Tech with bullish bias
Initiation	Adobe assumed with a Neutral at Citi » 06:20 03/03/21 03/03 06:20 03/03/21 06:20 ADBE Adobe $466.72 / -3.6 (-0.77%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ADBE Adobe $466.72 / -3.6 (-0.77%) 02/11/21 Adobe director sold 4K shares of common stock 02/02/21 Adobe EVP Rao sells 2,681 common shares 12/10/20 Adobe announces up to $15B new stock repurchase authority 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter ADBE Adobe $466.72 / -3.6 (-0.77%) 02/03/21 Wedbush Adobe price target raised to $510 from $410 at Wedbush 01/21/21 Goldman Sachs Adobe initiated with a Buy at Goldman Sachs 01/13/21 Stifel Adobe transferred with Buy rating at Stifel 12/11/20 BMO Capital Adobe price target raised to $570 from $560 at BMO Capital ADBE Adobe $466.72 / -3.6 (-0.77%) 12/10/20 Adobe sees FY21 EPS $11.20, consensus $11.17 12/10/20 Adobe sees Q1 EPS $2.78, consensus $2.59 12/10/20 Adobe reports Q4 EPS $2.81, consensus $2.66 12/09/20 Notable companies reporting before tomorrow's open ADBE Adobe $466.72 / -3.6 (-0.77%) 11/09/20 Adobe in advanced talks to acquire Workfront for $1.5B, Bloomberg reports 11/09/20 Adobe in talks to acquire Workfront for $1.5B, Bloomberg says ADBE Adobe $466.72 / -3.6 (-0.77%) 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Pre-market Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street ADBE Adobe $466.72 / -3.6 (-0.77%) 12/09/20 Adobe options imply 7.7% move in share price post-earnings 09/15/20 Adobe options imply 9.5% move in share price post-earnings
Periodicals	Samsung eyes four sites in U.S. for new $17B chip plant, Reuters reports » 06:19 03/03/21 03/03 06:19 03/03/21 06:19 SSNLF Samsung $0.00 / + (+0.00%) Samsung Electronics is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SSNLF Samsung $0.00 / + (+0.00%) 03/02/21 ITC to investigate certain cellular devices made by Samsung, Motorola Mobility 02/19/21 Solas OLED announces patent dispute settlement with LG Display 01/27/21 Samsung sees Memory business recovering during H1 01/17/21 Fly Intel: Top five weekend stock stories SSNLF Samsung $0.00 / + (+0.00%) 02/04/21 Craig-Hallum Qorvo price target raised to $195 from $160 at Craig-Hallum 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 01/29/21 Needham Skyworks price target raised to $245 from $200 at Needham 01/26/21 Applied Materials upgraded to Buy at DA Davidson on semicap strength SSNLF Samsung $0.00 / + (+0.00%) 01/27/21 Samsung sees overall profit weakening in Q1 01/27/21 Samsung reports Q4 operating profit KRW9.05T 01/07/21 Samsung sees Q4 operating profit KRW9.00T vs. KRW9.52T consensus 10/28/20 Samsung reports Q3 operating profit KRW12.35T vs KRW7.78T last year SSNLF Samsung $0.00 / + (+0.00%) 02/17/21 Samsung, NXP, Infineon have power shut off in Austin, AAS reports 02/05/21 Samsung eyes Austin, Texas for new $17B chip plant, Reuters reports 01/27/21 Samsung reports Q4 operating profit 9.05T won, Bloomberg says 01/25/21 Samsung may invest up to $17B in new U.S. chip factory, WSJ reports SSNLF Samsung $0.00 / + (+0.00%) 02/03/21 Fly Intel: What to watch in Qualcomm's earnings report 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021

Initiation	Atlassian assumed with a Buy at Citi » 06:19 03/03/21 03/03 06:19 03/03/21 06:19 TEAM Atlassian $244.40 / -7.25 (-2.88%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TEAM Atlassian $244.40 / -7.25 (-2.88%) 02/26/21 Atlassian acquires Chartio, terms not disclosed 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 TEAM Atlassian $244.40 / -7.25 (-2.88%) 01/29/21 DA Davidson Atlassian price target raised to $275 from $235 at DA Davidson 01/29/21 BMO Capital Atlassian price target raised to $260 from $235 at BMO Capital 01/29/21 Canaccord Atlassian price target raised to $260 from $225 at Canaccord 01/29/21 Cowen Atlassian price target raised to $255 from $250 at Cowen TEAM Atlassian $244.40 / -7.25 (-2.88%) 01/28/21 Atlassian reports Q2 EPS 37c, consensus 32c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c 10/29/20 Atlassian reports Q1 EPS (9c) incl. non-cash charge, consensus 27c TEAM Atlassian $244.40 / -7.25 (-2.88%) 01/28/21 Fly Intel: After-Hours Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday 10/30/20 Fly Intel: Wall Street's top stories at midday 10/29/20 Fly Intel: After-Hours Movers TEAM Atlassian $244.40 / -7.25 (-2.88%) 02/23/21 Atlassian call volume above normal and directionally bullish 02/22/21 Atlassian March 290 calls see heavy volume as shares dip 01/28/21 Atlassian options imply 11.5% move in share price post-earnings 12/21/20 Atlassian call volume above normal and directionally bullish
Downgrade	Associated British Foods downgraded to Sell from Neutral at Redburn » 06:17 03/03/21 03/03 06:17 03/03/21 06:17 ASBFY Associated British Foods $0.00 / + (+0.00%) Redburn analyst Emily… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ASBFY Associated British Foods $0.00 / + (+0.00%) 05:11 Today Redburn Associated British Foods downgraded to Sell from Neutral at Redburn 02/26/21 Barclays Associated British Foods price target raised to 2,700 GBp from 2,600 GBp at Barclays 02/23/21 Grupo Santander Associated British Foods upgraded to Buy from Hold at Grupo Santander 01/21/21 Berenberg Associated British Foods price target raised to 2,650 GBp at Berenberg
Hot Stocks	Patterson-UTI reports an average of 69 drilling rigs operating in February » 06:17 03/03/21 03/03 06:17 03/03/21 06:17 PTEN Patterson-UTI $7.57 / -0.305 (-3.87%) Patterson-UTI reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PTEN Patterson-UTI $7.57 / -0.305 (-3.87%) 02/03/21 Patterson-UTI reported average of 67 drilling rigs operating for January 01/06/21 Patterson-UTI reports an average of 64 drilling rigs operating in December 12/03/20 Patterson-UTI reports an average of 61 drilling rigs operating in November 11/04/20 Patterson-UTI reports an average of 61 drilling rigs operating in October PTEN Patterson-UTI $7.57 / -0.305 (-3.87%) 12/15/20 Citi Patterson-UTI price target raised to $6 from $3 at Citi 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound 07/16/20 Scotiabank Patterson-UTI downgraded to Underperform from Sector Perform at Scotiabank 05/28/20 Citi Patterson-UTI price target raised to $4.50 from $1.90 at Citi PTEN Patterson-UTI $7.57 / -0.305 (-3.87%) 02/04/21 Patterson-UTI reports Q4 EPS (57c), consensus (62c) 10/22/20 Patterson-UTI reports Q3 EPS (60c), consensus (62c)
Hot Stocks	U.S. District Court rules in AstraZeneca's favor in Symbicort patent litigation » 06:17 03/03/21 03/03 06:17 03/03/21 06:17 AZN AstraZeneca $47.72 / -0.38 (-0.79%) , MMM 3M $177.16 / +0.78 (+0.44%) , VTRS Viatris $14.28 / -0.46 (-3.12%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN MMM VTRS AZN AstraZeneca $47.72 / -0.38 (-0.79%) 03/02/21 AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 02/26/21 Amgen, AstraZeneca report 'positive' results from NAVIGATOR Phase 3 trial 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO MMM 3M $177.16 / +0.78 (+0.44%) 02/23/21 3M and Pegatron join to develop Virtual Reality headset 02/18/21 Stanley Black & Decker elects Jane Palmieri, Mojdeh Poul to board 02/16/21 3M to invest $1B over next 20 years to achieve carbon neutrality 02/16/21 Rockwell Automation appoints Nicholas Gangestad as CFO VTRS Viatris $14.28 / -0.46 (-3.12%) 02/22/21 Viatris to initiate 11c per share quarterly dividend in May 01/28/21 FTC approves final order on Pfizer, Mylan deal with conditions 12/21/20 Mapi Pharma provides enrollment update on Phase III GA Depot trial 12/18/20 Viatris acquires 27,736 common shares AZN MMM VTRS AZN AstraZeneca $47.72 / -0.38 (-0.79%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 UBS AstraZeneca upgraded to Buy from Neutral at UBS 02/04/21 Piper Sandler Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MMM 3M $177.16 / +0.78 (+0.44%) 02/03/21 Fly Intel: Top five analyst upgrades 02/03/21 Argus 3M upgraded to Buy from Hold at Argus 02/03/21 Argus 3M upgraded to Buy from Hold at Argus 01/27/21 Credit Suisse 3M price target lowered to $197 from $208 at Credit Suisse VTRS Viatris $14.28 / -0.46 (-3.12%) 03/02/21 JPMorgan Viatris downgraded to Neutral on 'modest' growth at JPMorgan 03/02/21 JPMorgan Viatris downgraded to Neutral from Overweight at JPMorgan 02/26/21 Wolfe Research Viatris downgraded to Peer Perform from Outperform at Wolfe Research 02/23/21 Barclays Viatris price target lowered to $20 from $26 at Barclays AZN MMM VTRS AZN AstraZeneca $47.72 / -0.38 (-0.79%) 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year MMM 3M $177.16 / +0.78 (+0.44%) 01/26/21 3M sees FY21 EPS $9.20-$9.70, consensus $9.52 01/26/21 3M reports Q4 adjusted EPS $2.38, consensus $2.15 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open VTRS Viatris $14.28 / -0.46 (-3.12%) 02/22/21 Viatris sees FY21 revenue $17.2B-$17.8B, consensus $18.46B AZN MMM AZN AstraZeneca $47.72 / -0.38 (-0.79%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 Germany to receive 16M AstraZeneca Covid vaccines in Q2, Reuters reports 02/23/21 AstraZeneca: COVID-19 vaccine could receive U.S. EUA by April, Reuters says MMM 3M $177.16 / +0.78 (+0.44%) 02/11/21 3M helping law enforcement stop sale of counterfeit N95 masks, CNBC reports 01/16/21 3M stock 'unloved, underpriced,' Barron's says 09/22/20 3M exploring possible sale of food safety division, Bloomberg says 09/22/20 3M exploring possible sale of food safety division, Bloomberg says AZN MMM AZN AstraZeneca $47.72 / -0.38 (-0.79%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday MMM 3M $177.16 / +0.78 (+0.44%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: Pre-market Movers 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN MMM VTRS AZN AstraZeneca $47.72 / -0.38 (-0.79%) 02/24/21 AstraZeneca call volume above normal and directionally bullish 02/17/21 AstraZeneca call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th MMM 3M $177.16 / +0.78 (+0.44%) 01/26/21 Unusually active option classes on open January 26th VTRS Viatris $14.28 / -0.46 (-3.12%) 03/02/21 Viatris put volume heavy and directionally bearish 02/19/21 Viatris call volume above normal and directionally bullish 02/08/21 Viatris put volume heavy and directionally bearish 01/14/21 Viatris call volume above normal and directionally bullish
Recommendations	Veeva price target raised to $350 from $340 at Piper Sandler » 06:16 03/03/21 03/03 06:16 03/03/21 06:16 VEEV Veeva $288.36 / -5.21 (-1.77%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VEEV Veeva $288.36 / -5.21 (-1.77%) 01/14/21 Veeva to become public benefit corporation on February 1 01/13/21 Veeva 'becomes first public company to convert to a public benefit corporation' 01/13/21 Veeva shareholders vote to convert to public benefit corporation 11/17/20 Veeva announces Bristol-Myers adoption of Vault PromoMats VEEV Veeva $288.36 / -5.21 (-1.77%) 02/17/21 KeyBanc Veeva price target raised to $353 from $332 at KeyBanc 01/13/21 Citi Elastic price target raised to $190 from $160 at Citi 01/11/21 Piper Sandler Veeva price target raised to $340 from $310 at Piper Sandler 01/11/21 Piper Sandler Bill.com price target raised to $140 from $120 at Piper Sandler VEEV Veeva $288.36 / -5.21 (-1.77%) 03/02/21 Veeva sees FY22 adjusted EPS $3.20, consensus $3.11 03/02/21 Veeva sees Q1 adjusted EPS 77c-78c, consensus 74c 03/02/21 Veeva reports Q4 adjusted EPS 78c, consensus 68c 12/01/20 Veeva sees FY22 revenue $1.7B-$1.72B, consensus $1.7B VEEV Veeva $288.36 / -5.21 (-1.77%) 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 12/01/20 Fly Intel: After-Hours Movers 10/14/20 Microsoft resumption, Nio upgrade among top calls on Wall Street

Earnings	AES Corp. backs FY21 adjusted EPS view $1.50-$1.58, consensus $1.56 » 06:15 03/03/21 03/03 06:15 03/03/21 06:15 AES AES Corp. $26.82 / -0.18 (-0.67%) Sees FY21 parent free… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AES AES Corp. $26.82 / -0.18 (-0.67%) 02/05/21 AES subsidiary IPL to acquire solar project in Clinton County 01/04/21 AES Corp. to sell Mong Duong 2 coal-fired plant in Vietnam 12/07/20 AES Corp. raises quarterly dividend by 5% to 15.05c per share 11/17/20 AES and AIMCo sign agreement for merger plan AES AES Corp. $26.82 / -0.18 (-0.67%) 01/11/21 BofA BofA US 1 List changes 09/18/20 Morgan Stanley AES Corp. price target raised to $23.50 from $19 at Morgan Stanley 08/13/20 BofA AES Corp. added to US 1 List; Ameren removed at BofA 05/20/20 Seaport Global Seaport Global starts power and competitive retail sector with positive outlook AES AES Corp. $26.82 / -0.18 (-0.67%) 02/25/21 AES Corp. sees FY21 adjusted EPS $1.50-1.58, consensus $1.56 02/25/21 AES Corp. reports Q4 EPS 47c, consensus 44c 11/06/20 AES Corp. reaffirms 7%-9% average annual growth target through 2022 11/06/20 AES Corp. backs FY20 adjusted EPS view $1.32 -$1.42, consensus $1.37 09:00 Today AES Corporation AES AES Corp. $26.82 / -0.18 (-0.67%) 11/20/20 AES Corp. call volume above normal and directionally bullish 10/15/20 AES Corp. call volume above normal and directionally bullish 09/24/20 AES Corp. call volume above normal and directionally bullish
Recommendations	ChampionX price target raised to $18 from $12.25 at Piper Sandler » 06:15 03/03/21 03/03 06:15 03/03/21 06:15 CHX ChampionX $21.86 / -0.94 (-4.12%) Piper Sandler analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHX ChampionX $21.86 / -0.94 (-4.12%) 01/19/21 ChampionX CFO Jayy Nutt to retire, Kenneth Fisher to succeed 12/21/20 ChampionX to transfer stock exchange listing to Nasdaq 11/16/20 ChampionX, Modumetal announce collaboration agreement CHX ChampionX $21.86 / -0.94 (-4.12%) 02/26/21 Barclays ChampionX price target raised to $29 from $23 at Barclays 02/25/21 Wells Fargo ChampionX price target raised to $24 from $19 at Wells Fargo 01/11/21 Barclays ChampionX price target raised to EUR 23 from EUR 19 at Barclays 12/21/20 Goldman Sachs ChampionX initiated with a Buy at Goldman Sachs CHX ChampionX $21.86 / -0.94 (-4.12%) 02/23/21 ChampionX reports Q4 EPS 7c, consensus 6c 10/28/20 ChampionX reports Q3 adjusted EPS 3c, consensus (4c)
Recommendations	Adidas price target lowered to EUR 284 from EUR 292 at Piper Sandler » 06:14 03/03/21 03/03 06:14 03/03/21 06:14 ADDYY Adidas $0.00 / + (+0.00%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly ADDYY Adidas $0.00 / + (+0.00%) 02/17/21 Adidas starts divestiture process for Reebok 12/14/20 Adidas assessing strategic alternatives for Reebok, including potential sale 09/24/20 Kanye West demands Gap board seat before product releases 09/10/20 Kohl's launches Adidas active collection with actress Zoe Saldana ADDYY Adidas $0.00 / + (+0.00%) 02/26/21 RBC Capital Adidas price target raised to EUR 300 from EUR 290 at RBC Capital 02/23/21 Credit Suisse Adidas upgraded to Neutral from Underperform at Credit Suisse 02/11/21 UBS Adidas upgraded to Buy from Neutral at UBS 02/01/21 Deutsche Bank Adidas price target raised to EUR 250 from EUR 240 at Deutsche Bank ADDYY Adidas $0.00 / + (+0.00%) 12/29/20 Reebok's $2.4B price tag brings new buyers to the table, Forbes reports 10/22/20 Adidas said to plan to sell Reebok business, Reuters reports ADDYY Adidas $0.00 / + (+0.00%) 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 09/22/20 Fly Intel: What to watch in Nike's earnings report
Periodicals	Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports » 06:14 03/03/21 03/03 06:14 03/03/21 06:14 JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) , MRNA Moderna $146.61 / -10.81 (-6.87%) , PFE Pfizer $33.51 / -0.185 (-0.55%) At least two Catholic… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA MRNA Moderna $146.61 / -10.81 (-6.87%) 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity 02/24/21 Moderna ships mRNA-1273.351 to NIH for clinical study 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan PFE Pfizer $33.51 / -0.185 (-0.55%) 03/02/21 Strata Oncology starts trial with Pfizer as partner 03/01/21 Flowserve supports Pfizer in production of COVID-19 vaccine 02/26/21 Pfizer: EMA accepts MAA for 20-valent pneumococcal conjugate vaccine candidate 02/26/21 Pfizer, Opko Health: EMA accepts marketing application for somatrogon JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRNA Moderna $146.61 / -10.81 (-6.87%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler PFE Pfizer $33.51 / -0.185 (-0.55%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/03/21 Mizuho Pfizer price target lowered to $42 from $44 at Mizuho JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRNA Moderna $146.61 / -10.81 (-6.87%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) PFE Pfizer $33.51 / -0.185 (-0.55%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 19 May JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says MRNA Moderna $146.61 / -10.81 (-6.87%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says PFE Pfizer $33.51 / -0.185 (-0.55%) 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday MRNA Moderna $146.61 / -10.81 (-6.87%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday PFE Pfizer $33.51 / -0.185 (-0.55%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/02/21 41st Annual Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ 03/24/21 Arthritis Advisory Committee and Drug Safety & Risk Mgmt Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 03/05/21 Pfizer JNJ MRNA PFE JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th MRNA Moderna $146.61 / -10.81 (-6.87%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish PFE Pfizer $33.51 / -0.185 (-0.55%) 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th
Recommendations	I-MAB price target raised to $75 from $55 at H.C. Wainwright » 06:12 03/03/21 03/03 06:12 03/03/21 06:12 IMAB I-MAB $59.12 / -4.98 (-7.77%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly IMAB I-MAB $59.12 / -4.98 (-7.77%) 02/25/21 I-MAB doses first patient in China Phase 3 growth hormone deficiency study 02/10/21 I-MAB's Phase 1 study of cancer candidate cleared by China's NMPA 02/05/21 I-Mab reports clinical advancements of antibody uliledlimab in China and U.S. 02/04/21 I-MAB says first patient dosed in Phase 2 clinical study of TJ107 IMAB I-MAB $59.12 / -4.98 (-7.77%) 02/25/21 Fly Intel: Top five analyst initiations 02/25/21 Piper Sandler I-MAB initiated with an Overweight at Piper Sandler 12/07/20 H.C. Wainwright I-MAB initiated with a Buy at H.C. Wainwright 09/08/20 Cantor Fitzgerald I-MAB price target raised to $55 from $50 at Cantor Fitzgerald 09 Feb 13 Jan IMAB I-MAB $59.12 / -4.98 (-7.77%) 09/04/20 Fly Intel: Wall Street's top stories for Friday 09/04/20 Fly Intel: Wall Street's top stories at midday

Periodicals	Apple could launch foldable iPhone as soon as 2023, Business Insider reports » 06:12 03/03/21 03/03 06:12 03/03/21 06:12 AAPL Apple $125.17 / -2.6 (-2.03%) A foldable iPhone could… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 Target to open approx. 100 Ulta Beauty at Target shop-in-shops in 2021 02/25/21 Target announces enhanced Apple shopping experience for customers 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/19/21 Energous jumps 53% on Bloomberg report that Apple is working on battery pack AAPL Apple $125.17 / -2.6 (-2.03%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle AAPL Apple $125.17 / -2.6 (-2.03%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 New Apple Card users get 6% Daily Cash on Apple purchases, 9to5Mac says 03/01/21 New EU 'Right to Repair' rules require goods to be repairable, Independent says 03/01/21 All Apple stores in U.S. open for first time since pandemic, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 03/17/21 Technology AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 Notable open interest changes for March 2nd 03/02/21 Apple call buyer realizes 91% same-day gains 03/01/21 Notable open interest changes for March 1st 02/26/21 Notable open interest changes for February 26th
Hot Stocks	Dycom announces new $150M share repurchase plan » 06:11 03/03/21 03/03 06:11 03/03/21 06:11 DY Dycom $77.36 / -3.6 (-4.45%) Dycom announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DY Dycom $77.36 / -3.6 (-4.45%) 01/15/21 Dycom COO sells 52K shares of common stock 12/16/20 Dycom COO sells 150.1K shares of common stock 11/24/20 Dycom falls -17.3% 11/24/20 Dycom falls -15.6% DY Dycom $77.36 / -3.6 (-4.45%) 01/27/21 KeyBanc Dycom upgraded to Overweight at KeyBanc 01/27/21 KeyBanc Dycom upgraded to Overweight from Sector Weight at KeyBanc 01/07/21 B. Riley Securities Dycom price target raised to $97 from $92 at B. Riley Securities 11/25/20 DA Davidson Dycom price target raised to $80 from $60 at DA Davidson DY Dycom $77.36 / -3.6 (-4.45%) 06:06 Today Dycom sees Q1 revenue in-line to modestly lower than Q4, consensus $786.14M 06:04 Today Dycom reports Q4 EPS (7c), consensus 4c 11/24/20 Dycom sees modestly lower contract revenues in Q4, consensus $744.13M 11/24/20 Dycom reports Q3 adj. EPS $1.06, consensus $1.05 09:00 Today Dycom - DY 03/31/21 Dycom
Recommendations	Amyris price target raised to $35 from $11 at H.C. Wainwright » 06:11 03/03/21 03/03 06:11 03/03/21 06:11 AMRS Amyris $19.91 / +4.29 (+27.46%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AMRS Amyris $19.91 / +4.29 (+27.46%) 03/01/21 Amyris to acquire Costa Brazil brand, terms not disclosed 02/24/21 Amyris launches Pipette clean baby care brand in Target 02/22/21 Amyris announces pre-clinical results for COVID RNA vaccine platform 02/02/21 Amyris announces results from clinical study of clean topical formulation AMRS Amyris $19.91 / +4.29 (+27.46%) 02/26/21 Fly Intel: Top five analyst initiations 02/26/21 Roth Capital Amyris initiated with a Buy at Roth Capital 01/06/21 Cowen Amyris upgraded to Outperform with $9 price target at Cowen 01/06/21 Cowen Amyris upgraded to Outperform from Market Perform at Cowen AMRS Amyris $19.91 / +4.29 (+27.46%) 03/02/21 Amyris sees FY21 revenue $400M, consensus $231.77M 03/02/21 Amyris reports Q4 adjusted EPS (3c), consensus (9c) AMRS Amyris $19.91 / +4.29 (+27.46%) 03/02/21 Fly Intel: Wall Street's top stories at midday 09/15/20 Fly Intel: Wall Street's top stories for Tuesday 09/15/20 Fly Intel: Wall Street's top stories at midday 09/11/20 Fly Intel: Wall Street's top stories for Friday 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference AMRS Amyris $19.91 / +4.29 (+27.46%) 01/04/21 Amyris call volume above normal and directionally bullish 12/30/20 Amyris call volume above normal and directionally bullish 12/28/20 Amyris call volume above normal and directionally bullish 12/24/20 Unusual call flow in option market yesterday
Hot Stocks	Mack-Cali Realty names Mahbod Nia CEO » 06:10 03/03/21 03/03 06:10 03/03/21 06:10 CLI Mack-Cali Realty $14.24 / +0.11 (+0.78%) , NRE Northstar Realty Europe $17.02 / + (+0.00%) Mack-Cali Realty (CLI)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CLI CLI Mack-Cali Realty $14.24 / +0.11 (+0.78%) 01/06/21 Mack-Cali Realty sells Riverwatch Commons, Crystal House Apartments 12/03/20 Mack-Cali Realty announces $61M sale of NJ property 11/23/20 Mack-Cali Realty sells Parsippany, NJ property to Birch Group for $12.75M. 09/30/20 Mack-Cali Realty suspends dividend for Q3, Q4 CLI NRE CLI Mack-Cali Realty $14.24 / +0.11 (+0.78%) 12/10/20 Citi Citi opens '90-day negative Catalyst Watch' on Mack-Cali Realty 08/04/20 Fly Intel: Top five analyst downgrades 08/04/20 Deutsche Bank Mack-Cali Realty downgraded to Hold from Buy at Deutsche Bank 07/20/20 Deutsche Bank Mack-Cali Realty price target lowered to $20 from $22 at Deutsche Bank NRE Northstar Realty Europe $17.02 / + (+0.00%) CLI CLI Mack-Cali Realty $14.24 / +0.11 (+0.78%) 02/25/21 Mack-Cali Realty sees Q1 FFO 12c-15c, one estimate 27c 02/25/21 Mack-Cali Realty reports Q4 FFO 16c, consensus 24c 11/04/20 Mack-Cali Realty reports Q3 core FFO 30c, consensus 29c
Downgrade	Kopin downgraded to Neutral from Buy at H.C. Wainwright » 06:09 03/03/21 03/03 06:09 03/03/21 06:09 KOPN Kopin $9.92 / +0.78 (+8.53%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options KOPN Kopin $9.92 / +0.78 (+8.53%) 02/23/21 Kopin director Collins sells almost $2M in company shares 02/23/21 Kopin trading resumes 02/23/21 Kopin trading halted, volatility trading pause 02/02/21 Kopin, HMDmd in development pact for wearable display system for surgeons KOPN Kopin $9.92 / +0.78 (+8.53%) 01/11/21 H.C. Wainwright Kopin price target raised to $3.50 from $2 at H.C. Wainwright 08/25/20 Fly Intel: Top five analyst initiations 08/25/20 H.C. Wainwright Kopin initiated with a Buy at H.C. Wainwright 08/05/20 Ladenburg Kopin price target raised to $2.50 from $1.50 at Ladenburg KOPN Kopin $9.92 / +0.78 (+8.53%) 11/03/20 Kopin reports Q3 EPS (1c), consensus (2c) KOPN Kopin $9.92 / +0.78 (+8.53%) 03/02/21 Unusually active option classes on open March 2nd

Events

Earnings calls, analyst events, roadshows and more

PUK
Today at 06:30

Prudential plc - PUK Conference Calls
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 2/26/2021 Government Event
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim $18.00-18.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel $29.00-30.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Freeport McMoRan downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

Get Full Fly Access